Kevin P. Smith - 01 Sep 2026 Form 4 Insider Report for Inogen Inc (INGN)

Reporting relationship: EVP, Bus Dev, GC & Sec
Issuer ticker: INGN
Reported as of: 01 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Sep 2026, 17:01:02 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mary Wright, as Attorney-in-Fact

Key filing fact

Kevin P. Smith filed Form 4 for Inogen Inc (INGN) on 03 Sep 2026.

Key facts

This page summarizes Kevin P. Smith's Form 4 filing for Inogen Inc (INGN).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Sep 2026, 17:01.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002031211 Primary reporting owner

Smith Kevin P.

Relationship: EVP, Bus Dev, GC & Sec
Address: C/O INOGEN, INC., 500 CUMMING CENTER, SUITE 2800, BEVERLY
Signature: /s/ Mary Wright, as Attorney-in-Fact
Signature date: 03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INGN transaction

Common Stock

Award

Transaction value
Shares: +1,500
Change %: +6.8%
Price: $5.33^*
Shares after: 23,507
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1

INGN transaction

Common Stock

Options Exercise

Transaction value
Shares: +18,136
Change %: +77%
Price: $0.000000^*
Shares after: 41,643
Date: 01 Sep 2026
Ownership: Direct

INGN transaction

Common Stock

Tax liability

Transaction value
Shares: -8,671
Change %: -21%
Price: $5.33^*
Shares after: 32,972
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -18,136
Change %: -50%
Price: $0.000000^*
Shares after: 18,135
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,136
Exercise price
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Shares acquired through the Company's 2014 Employee Stock Purchase Plan.

Footnote F2

The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on September 1, 2026.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

Footnote F4

1/3rd of the restricted stock units vested on September 1, 2026 (the "Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.